跳至主要内容
临床试验/NCT00990951
NCT00990951暂停3 期

Double-blind, Randomized, Placebo-controlled Study of Efficacy of Association of Senna Alexandrina, Cassia Fistula, Tamarindus Indica, Coriandrum Sativum, Periandra Mediterranea in Patients With Functional Intestinal Constipation

Marjan Industria e Comercio ltda1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
暂停
入组人数
80
试验地点
1
主要终点
average frequency of bowel movements measured at baseline and at 2 weeks of treatment

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of association of Senna alexandrina Mill (sena), Cassia fistula L., Tamarindus indica L., Coriandrum sativum L., Periandra mediterranea Taub. in patients with functional constipation.

详细描述

This is a phase III trial, placebo-controlled with a parallel-group design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between 18-65 years with functional constipation by ROME IIII criteria
  • In the opinion of the investigator the patient will adhere to the protocol
  • Voluntary able to understand the nature and purpose of the study, including the risks and adverse effects and with intent to cooperate with the researcher and act in accordance with the requirements of the entire protocol, which was confirmed by signing the Consent Informed

排除标准

  • hypersensitivity to any component
  • pregnant or lactating
  • abdominal pain of unknown etiology
  • suspected intestinal occlusion and sub-occlusion
  • suspected abdominal inflammatory conditions (as appendicitis, peritonitis, cystitis, endometritis)
  • Crohn disease and colitis
  • Suspected intestinal constipation due abdominal surgery, neurological disorders (as aganglionoses, Parkinson disease, medullar tumor, stroke, multiple sclerosis), systemic sclerosis, multiple myeloma, scleroderma
  • Subjects with congenital mega colon, anorectal congenital malformation, inflammatory bowel disease or intestinal carcinoma
  • history of mal-absorption diseases
  • history of anemia, weight loss or anal bleeding
  • history of hypothyroidism, hyperthyroidism and insulin-dependent diabetes mellitus
  • known of positive result for human immunodeficiency virus test
  • heart, liver, lung or kidney important condition
  • drug or alcohol dependence
  • knowledge or suspicion of malignancy
  • body mass index < 18
  • body mass index > 30
  • participation on any experimental study 12 months prior this study
  • familiar history of colon carcinoma or inflammatory disease
  • Lack of adherence to the procedures of the protocol

研究组 & 干预措施

Senna alexandrina and associations

Experimental

Association of Senna alexandrina Mill (sena), Cassia fistula L., Tamarindus indica L., Coriandrum sativum L., Periandra mediterranea Taub

干预措施: Senna alexandrina and associations (Drug)

结局指标

主要结局

average frequency of bowel movements measured at baseline and at 2 weeks of treatment

时间窗: 2 weeks

次要结局

  • degree of improvement of constipation according to the subjective evaluation of the volunteer, measured by the scores of the Global Assessment of the patient(2 weeks)
  • Proportion of stools with pain and difficulty(2 weeks)
  • number of consecutive days that patients do not evacuate(2 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study of Efficacy of Association of Senna... | 临床试验